ECIM 2025 saw a heated discussion on whether anticoagulation in DVT should be treated like a chronic condition, as new ...

Trials evaluating anticoagulation in patients hospitalized for COVID-19 did not consistently favor stepping up dosing for ...

Even with recommendations in place, hospitals were far from uniform in their anticoagulation approaches well into 2022.

A risk-assessment tool incorporating NT-proBNP and high-sensitivity troponin performs better than clinical scores for ...

There is an apparent underuse of warfarin in elderly patients with AF, as there is inconsistency in opinion among clinicians about who should receive anticoagulation. The risks of warfarin are ...

The following is a summary of “Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease: ...

A new study suggests that the benefits of prescribing anticoagulation drugs to certain older people outweigh the potential risks. For patients with atrial fibrillation, the risk of stroke or heart ...

"Appropriate investigations for a source of bleeding may also increase confidence in resuming anticoagulation if the underlying cause is addressed, or no serious pathology is uncovered." ...

Opens in a new tab or window A population-based cohort study found an association between bleeding events in Afib patients on oral anticoagulation and cancer diagnoses. In cases where cancer was ...

Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a late-stage biopharmaceutical company focused on the development of specialized ...

In reconstructive surgery, specifically free flap reconstructive surgery, concerns persist regarding the risk of failures due ...

In this randomized controlled trial, among patients with atrial fibrillation requiring anticoagulation therapy, asundexian ...